OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
August 02, 2009
Biologics enhance their positions amidst slowing growth in the global and US markets.
In the aftermath of recent restructuring, Big Pharma is sporting a reduced global manufacturing footprint while intensifying its focus to biologics and emerging markets. What will be the look of tomorrow's manufacturing networks?
August 01, 2009
Leading experts share their perspective on the specialized requirments when developing a pediatric formulation and examine dosage forms that can be used for this patient class in this roundtable moderated by Patricia Van Arnum.
Leading contract manufacturing organizations share their views on the current and future market dynamics shaping pharmaceutical outsourcing.
July 30, 2009
In a move to strengthen development of its biologics portfolio, Bristol-Myers Squibb (BMS, New York) has agreed to acquire the biopharmaceutical company Medarex (Princeton, NJ) for $16 per share or approximately $2.4 billion.
July 16, 2009
The Society of Chemical Manufacturers and Affiliates (SOCMA) this week stated its support to the US Senate for approving legislation that would extend existing chemical security standards for one more year.